By Will Boggs, MD NEW YORK (Reuters Health) – Temsirolimus does not improve progression-free survival in metastatic renal cell carcinoma (RCC) compared to standard treatment, according to results…
NEW YORK (Reuters Health) – In patients with potentially resectable colorectal liver metastases, the use of combined PET and CT imaging (PET-CT) identifies those with occult extrahepatic disease…
Recent Videos in Reuters Health • The Doctor’s Channel Newscast Page 117
NEW YORK (Reuters Health) – In looking back at patients admitted to a medical ICU in Olmsted County, Minnesota in 2006, clinicians found that those who were on…
NEW YORK (Reuters Health) – In metformin-treated patients with type 2 diabetes, exenatide twice daily improves glycemic control to the same degree as insulin aspart twice daily, but…
NEW YORK (Reuters Health) – For patients who require stroke prevention therapy and who also undergo coronary stenting, combining oral anticoagulation with aspirin and clopidogrel provides better antithrombotic…
NEW YORK (Reuters Health) – Compared to the standard 75-mg/d maintenance dose of clopidogrel, 150 mg/d produces greater platelet inhibition, higher flow-mediated vasodilation, and reduced inflammation – all…
NEW YORK (Reuters Health) – Compared with digital subtraction angiography, computed tomographic angiography is only about half as sensitive in identifying cerebrovascular injuries resulting from blunt trauma, reports…
NEW YORK (Reuters Health) – For patients undergoing coronary artery bypass surgery, discontinuing chronic aspirin therapy at least 6 days before or within 5 days of surgery has…
NEW YORK (Reuters Health) – Although quite rare, local reactions to the fifth dose of diphtheria/tetanus/acellular-pertussis (DTaP) vaccine in children are more likely when the vaccine is injected…
NEW YORK (Reuters Health) – For mild persistent asthma, fluticasone propionate with salmeterol cuts the risk of exacerbations more than ciclesonide, but both regimens effectively control daily symptoms.…
NEW YORK (Reuters Health) – In patients with stage 1 and 2 hypertension, the experimental angiotensin receptor blocker (ARB) azilsartan medoxomil lowers blood pressure better than maximal doses…
NEW YORK (Reuters Health) – An analysis of “real-life” data from a French myocardial infarction (MI) registry fails to show any clinically relevant interaction between clopidogrel and proton…
